CJC-1295 No DAC + Ipamorelin Research Blend
This listing combines two separately named research materials: “CJC-1295 No DAC,” a catalogue term commonly used for a modified growth-hormone-releasing-hormone fragment, and Ipamorelin, a synthetic pentapeptide described in preclinical pharmacology literature as a growth-hormone-secretagogue receptor agonist.
“CJC-1295 No DAC” must be distinguished from long-acting, DAC-conjugated CJC-1295. Published studies of DAC-conjugated CJC-1295 do not establish the properties of a No-DAC material or this blend. Supplier nomenclature can also vary, so laboratories should confirm sequence, terminal modifications, expected molecular mass, component ratio and lot-specific characteristics.
Available Formats
- 10 mg CJC-1295 No DAC + 10 mg Ipamorelin vial
- 20 mg CJC-1295 No DAC + 20 mg Ipamorelin vial
- 10 × 10 mg/10 mg box
- 10 × 20 mg/20 mg box
- Lyophilized blend
Catalogue Comparison
For single-material listings, see CJC-1295 No DAC and Ipamorelin. Each has its own identity and handling requirements and is not interchangeable with this blend.
Material Review and Handling
Match the product and lot identifier to the label and accompanying documentation before use. Identity, component ratio, content or fill amount, analytical characteristics and storage requirements are distinct attributes and should be reviewed separately. Follow the storage condition stated for the specific product and lot.
Browse Peptide Blends or review our laboratory storage and handling guide.
Research-Use Notice
For controlled laboratory research only. Not for human or veterinary use.






